PATENT CLAIM ANALYSIS

Application Number: 15777349
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["424", "499000"]

Abstract:
Biocompatible particles comprising a metallic core and a plurality of drug-loading ligands coordinated to the metallic core are described. The metallic core can, for example, have a melting point of 100° C. or less. The biocompatible particles can, in some examples, further comprise a therapeutically effective amount of a drug coordinated to the plurality of drug-loading ligands. In some examples, the biocompatible particles can further comprise a plurality of targeting ligands coordinated to the metallic core. Also disclosed herein are methods of making the biocompatible particles described herein, for example using sonication. Also disclosed herein are methods of treating cancer in a subject comprising administering to the subject a therapeutically effective amount of the biocompatible particles or compositions disclosed herein.

Claim (Index 4):
The biocompatible particle of  claim 1 , wherein the metallic core comprises gallium, indium, tin, zinc, or a combination thereof.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 93.0
- Lexical Diversity: 2.49057
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14651860', '15221832', '12928878', '15413267', '13820351']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7328804282044151
- 35 USC 102 Novelty (BERT): 0.5138127620259345
- Combined Prediction Score: 0.710973661586567
- Mean Citation Score: 221.372368
- Max Citation Score: 230.52052
- Similarity Product: 129.11519341125015

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test